Thomas Garite - 26 Aug 2021 Form 4 Insider Report for SERA PROGNOSTICS, INC. (SERA)

Role
VP, Clinical Sciences
Signature
/s/ Nishant Dharia, Attorney-in-fact
Issuer symbol
SERA
Transactions as of
26 Aug 2021
Net transactions value
$0
Form type
4
Filing time
09 Sep 2021, 17:49:08 UTC
Previous filing
14 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SERA Stock Option (right to buy) Award $0 +10,000 $0.000000 10,000 26 Aug 2021 Class A Common Stock 10,000 $9.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to this option will vest monthly beginning on September 26, 2021, subject to the Reporting Person's continued service to the Issuer through each such vesting date.